Sign In
Buy LLY
$1,231.58
+45.87 (+3.87%)
At Close: Aug 10, 2026
Why the FDA's Rejection of Eli Lilly's Alzheimer's Drug Is Actually Great News for the Stock
09:53am, Wednesday, 01'st Feb 2023
Ironically, it was the drug's own effectiveness that led to the FDA not granting approval.
FDA Pulls EUA Granted to AstraZeneca's (AZN) Evusheld
03:26pm, Friday, 27'th Jan 2023 Zacks Investment Research
AstraZeneca's (AZN) Evusheld is no longer authorized for use in the United States after laboratory data showed that it does not neutralize Omicron subvariants.
Biogen (BIIB) & Eisai's Lecanemab Secures EMA's MAA Acceptance
02:57pm, Friday, 27'th Jan 2023 Zacks Investment Research
Biogen (BIIB) and Eisai jointly announce that EMA accepts lecanemab's marketing authorization application (MAA) for the treatment of patients with early-stage Alzheimer's disease, for review.
Eli Lilly (LLY) to Report Q4 Earnings: What's in the Cards?
01:23pm, Friday, 27'th Jan 2023 Zacks Investment Research
Higher demand for its key drugs is likely to have offset generic competition for several other drugs and may have boosted Lilly's (LLY) fourth-quarter sales.
Pharma Stock Roundup: JNJ Q4 Results Mixed, MRK Keytruda Prostate Cancer Study Ends
01:14pm, Friday, 27'th Jan 2023 Zacks Investment Research
J&J (JNJ) reports mixed fourth-quarter results. Merck (MRK) discontinues an advanced prostate cancer study on blockbuster drug Keytruda for futility.
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
11:50am, Friday, 27'th Jan 2023 The Motley Fool
These companies have the therapies to boost revenue for a decade.
Could This New Drug Indication Be a Winner for Eli Lilly?
03:15pm, Thursday, 26'th Jan 2023 The Motley Fool
The FDA could be just months away from approving Eli Lilly and Boehringer Ingelheim's drug candidate to treat a common condition.
Is It Too Late to Buy Eli Lilly Stock?
02:38pm, Thursday, 26'th Jan 2023 The Motley Fool
At a $325 billion market cap, the business is already huge -- does it have much more room to grow?
Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know
02:00pm, Thursday, 26'th Jan 2023 Zacks Investment Research
Lilly (LLY) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Could This New Drug Indication Be a Winner for Eli Lilly?
10:15am, Thursday, 26'th Jan 2023
The FDA could be just months away from approving Eli Lilly and Boehringer Ingelheim's drug candidate to treat a common condition.
Is It Too Late to Buy Eli Lilly Stock?
09:38am, Thursday, 26'th Jan 2023
At a $325 billion market cap, the business is already huge -- does it have much more room to grow?
10 Biggest Companies Reporting Earnings in the First Week of Feb 2023
10:56pm, Wednesday, 25'th Jan 2023
The fourth quarter earnings season for the S&P 500 didn't get off to a strong start.
2 Ultra-Safe Dividend Stocks to Own in 2023
02:30pm, Wednesday, 25'th Jan 2023 The Motley Fool
These two top dividend stocks won't keep you up at night.
Eli Lilly: Far From Dead In Alzheimer's, But Needs Help From Other Areas
02:12pm, Wednesday, 25'th Jan 2023
The recent FDA complete response letter to Eli Lilly and Company about donanemab was inevitable. Approval of donanemab remains uncertain.
Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?
11:20am, Wednesday, 25'th Jan 2023 Zacks Investment Research
Sector ETF report for FHLC
